sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals North America Kidney Disease Market...

North America Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Diagnosis and Treatment); End User (Hospitals, Diagnostic Laboratories, and Others); and Country

TIPRE00016072 | Pages: 142 | Pharmaceuticals | Nov 2020 | Type: Regional | Status: Published

Market Introduction

Kidney disease is also known as renal disease. It is caused due to the malfunctioning of the kidney. There are various types of kidney diseases including kidney stones, glomerulonephritis, urinary tract infections, and others. For the treatment and diagnosis of these types of diseases, different global and regional players are offering various products and services.


Get more information on this report :



Market Overview and Dynamics

TheNorth Americakidney disease market is expected to reach US$ 42,462.1 million in 2027 from US$ 25,483.5million in 2019. The market is estimated to grow with a CAGR of 6.7% from 2020-2027. The growth of the market is attributed to some key driving factors such asan increasing prevalence of chronic kidney related diseases and a high growth in aging population. However, the market is expected experiencing slow growth during the forecast period owing to failure in diagnosing cases of kidney diseases.

Key Market Segments

Based on product, the kidney disease market is segmented diagnosis and treatment. The diagnosis segment is further sub-segmented into blood tests, urine tests, imaging tests, and others. The treatment segment is further sub-segmented into dialysis, drug class, and others. The drug class is sub-divided into ACE inhibitors, angiotensin-2 receptor blockers, diuretics, and others.Based on end-user, the kidney disease market, is segmented into hospitals, diagnostic laboratories,and others.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources forkidney disease market included in the report are American Urological Association, National Kidney Foundation,Kidney International Report, and others.

 

Reasons to buy the report

  • To understand the North Americakidney disease market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for kidney disease market
  • Efficiently plan M&A and partnership deals in North America kidney disease market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment formKidney disease market
  • Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region

 

NORTH AMERICA KIDNEY DISEASE MARKET SEGMENTATION

By Product

·         Diagnosis

o      Blood Tests

o      Urine Tests

o      Imaging Tests

o      Others

·         Treatment

o      Dialysis

o      Others

o      Drug Class

§   ACE Inhibitors

§   Angiotensin-II Receptor Blockers

§   Diuretics

§   Others

By End User

·         Hospitals

·         Diagnostic Laboratories

·         Others

By Country

·         North America

o      US

o      Canada

o      Mexico

 

Company Profiles

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • AbbVie Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Amgen Inc.
  • Sysmex Corporation
  • Siemens AG
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Kidney Disease Market – By Product

1.3.2        Kidney Disease Market – By End User

1.3.3        North America Kidney Disease – By Country

2.           North America Kidney Disease – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Kidney Disease – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Kidney Disease Market- North America PEST Analysis

4.3         Expert Opinion

5.           North America Kidney Disease - Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Chronic Kidney Related Diseases

5.1.2        High Growth in Aging Population

5.2         Market Restraints

5.2.1        Failure in Diagnosing Cases of Kidney Disease

5.3         Market Opportunities

5.3.1        A High Rise in Research & Development  Regarding  Kidney Diseases

5.4         Future Trends

5.4.1        Multiple Product Launches and Strategies

5.5         Impact Analysis

6.           Kidney Disease Market – North America Analysis

6.1         North America Kidney Disease Revenue Forecasts and Analysis

7.           North America Kidney Disease Analysis and Forecasts To 2027 – ByProduct

7.1         Overview

7.2         Kidney Disease Market Revenue Share, by Product (2019 and 2027)

7.3         Diagnosis

7.3.1        Overview

7.3.2        Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.3        Blood Tests

7.3.3.1          Overview

7.3.3.2          Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027(US$ Million)

7.3.4        Urine Tests

7.3.4.1          Overview

7.3.4.2          Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.5        Imaging Tests

7.3.5.1          Overview

7.3.5.2          Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.3.6        Others

7.3.6.1          Overview

7.3.6.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Treatment

7.4.1        Overview

7.4.2        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Drug Class

7.4.3.1          Overview

7.4.3.2          Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.1          ACE Inhibitors

7.4.3.2.1.1       Overview

7.4.3.2.1.2       ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.2          Angiotensin-II Receptor Blockers

7.4.3.2.2.1       Overview

7.4.3.2.2.2       Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.3          Diuretics

7.4.3.2.3.1       Overview

7.4.3.2.3.2       Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3.2.4          Others

7.4.3.2.4.1       Overview

7.4.3.2.4.2       Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.4        Dialysis

7.4.4.1          Overview

7.4.4.2          Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

7.4.5        Others

7.4.5.1          Overview

7.4.5.2          Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.           North America Kidney Disease Analysis – By End-User

8.1         Overview

8.2         Kidney Disease Market Revenue Share, by End User (2019 and 2027)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

9.           Kidney Disease Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         North America: Kidney Disease Market

9.1.1        Overview

9.1.2        North America: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        North America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.3.2.1          North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.4        North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.5        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

9.1.6        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          US: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.1          US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2          US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.6.2.2.1       US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.7        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Canada: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.1          Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2          Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.7.2.2.1       Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

9.1.8        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Mexico: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.1          Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2          Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

9.1.8.2.2.1       Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.        Impact Of COVID-19 Pandemic on North America Kidney Disease

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        COMPANY PROFILES

11.1      Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      F. Hoffmann-La Roche Ltd.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      AbbVie Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Pfizer Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

Source: Press Release, Newsletters, and Company Annual Report

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of terms

LIST OF TABLES

Table 1.             North America: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Kidney Disease Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: Kidney Disease Market, by Diagnosis – Revenue and Forecast to 2027 (USD Million)

Table 18.          Mexico: Kidney Disease Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Kidney Disease Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Kidney Disease Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Glossary of Terms,Kidney disease

LIST OF FIGURES

Figure 1.           Kidney Disease Segmentation

Figure 2.           North America Kidney Disease Overview

Figure 3.           Diagnosis Segment Held Largest Share of Product in Kidney Disease Market

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Kidney Disease Market - North America PEST Analysis

Figure 6.           Kidney Disease Market Impact Analysis of Driver and Restraints

Figure 7.           North America Kidney Disease – Revenue Forecasts and Analysis – 2019- 2027

Figure 8.           Kidney Disease Market Revenue Share, by Product (2019 and 2027)

Figure 9.           Diagnosis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10.        Blood Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Urine Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Imaging Tests: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Treatment: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Drug Class: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        ACE Inhibitors: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Angiotensin-II Receptor Blockers: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Dialysis: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Kidney Disease Market Revenue Share, by End User (2019 and 2027)

Figure 23.        Hospitals: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Diagnostic Laboratories: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Others: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        North America: Kidney Disease Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        North America: Kidney Disease Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        North America: Kidney Disease Market, by Country, 2019 & 2027 (%)

Figure 29.        US: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Canada: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Mexico: Kidney Disease Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in North American Country Markets

 

The List of Companies - North America Kidney Disease Market

  1. Abbott
  2. F. Hoffmann-La Roche Ltd
  3. AbbVie Inc.
  4. Pfizer Inc.
  5. Teva Pharmaceutical Industries Ltd
  6. GlaxoSmithKline plc.
  7. Amgen Inc.
  8. Sysmex Corporation
  9. Siemens AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America kidney diseasemarket.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022
Purchase Options
Single User License
$3000
$1500
Site License
$4000
$2000
Enterprise License
$5000
$2500
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription